Loading clinical trials...

A Study of LY3473329 in Healthy Japanese Participants | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT05038787

A Study of LY3473329 in Healthy Japanese Participants

The main purpose of this study is to evaluate the safety and tolerability of LY3473329 in healthy Japanese participants. The study will also assess how fast LY3473329 gets into the blood stream and ho...

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

RECRUITINGNA

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 21, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment24

Start dateNov 2021

Last updatedJun 21, 2022

Condition

Healthy

Locations shown

Altasciences Clinical Los Angeles, Inc

Cypress, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of LY3473329 in Healthy Japanese Participants

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cytapheresis of Volunteer Donors

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Sodium vs Potassium Education to Improve Vascular Health

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

Trial snapshot

Condition

Locations shown

For caregivers